av/heat-biologics--big.svg

AMEX:HTBX

Heat Biologics, Inc.

  • Stock

2.38

+0.42%

0.01

USD last updated 29/07 01:36:25

Last Close

2.37

03/05 04:00

Market Cap

61.07M

Beta: 0.30

Volume Today

43.61K

Avg: 155.10K

PE Ratio

−1.69

PFCF: -

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Heat Biologics, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activat...Show More

    Earnings

    Earnings per Share (Estimate*)

    -60-50-40-30-20-102013-03-312015-03-272016-12-302018-11-142020-08-07

    Revenue (Estimate*)

    -500K500K1M1.50M2M2.50M3M2013-03-312015-03-272016-12-302018-11-142020-08-07

    *Estimate based on analyst consensus